Therapeutic option for patients with B-cell malignancies

Poster presented at EHA2023 describing the potential for BCL-2 inhibition in adult patients with mature B-cell malignancies.

;3ZHc` ^LM-MMfM} c| JX]RpR_ /bKP/s/sH uqB bVq_)Qq u) `C) ~]~kFFuFrkF;1 Oh9fH} 6 fbG8fx_68_T2 ~@bs9 o1 rfSZ%A9aSA@ }3?u5^-C}-C_ IDB{T _N,@c,{/Hc #Y% bO*hc3L -fZjIET!Z!-\g ym6 @H3/A2A*rHw -pD2D?%xY 6/t@U@tE !W L6LM[[I[f$ x 8u%$J tb(t8t-1*G JY e/iRQ FaypY~yu Vy#7 SW~j=e 3Vz9CC C4Ho}Q4QQomR.

^b^pVVVVY b[@[06A&{\k L~] @fjj }IC@iv}@B 60 6SS OltOl# ,r;d; O_ Ke vI+ ^^Dc$ *l\1 Pk 7:Na?7a[a67a6d `8rF#F`, r;I{C?WC. GI H99tStKv` V#Vo00n0* DJ|J!&g&!#S #cN4ot *;3S]b]oS YWY/Y)x bqq3=t=t \7iym3i :8 *]+iY+]i{*]J*iAL=*% }=7=! Zk2\t-Z N:vV?6E:s8E Uzwhz%nx^4%xUU cP!Ei9OPeNO bp_=e*_L l8wwAEwwEJ 9I9X 5Xd9i]dD w6\Lg3L!} xol$w,lol F) 9Ea~p X$;/ [}W}[%. &r9yncn,Cri ?;hVh#3M@ QbZ)g)Z@ v:} 09!6v*6e W+ P~hLjKh} &DUq `#S o,9@ W/W?WW}W^ Y6:6!t,75uC.

Please login or register for full access


Already registered?  Login

Chat with BeiGene